Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients.
暂无分享，去创建一个
D. Blaise | M. Mohty | P. Moreau | H. Avet-Loiseau | O. Reman | J. Harousseau | N. Milpied | F. Nicolini | M. Sobh | M. Attal | R. Tabrizi | M. Michallet | J. Cornillon | S. Morisset | A. Sîrvent | H. Labussière | J. El-Cheikh | A. Sirvent